Skip to content
Pharma Observatory a Scientist.com platform
  • Supplier site
  • Group of sites (click to zoom)

Scientist.com supplier network (site locations)

Research supplier

ICE Bioscience

ICE Bioscience is listed as a small business research supplier in the Scientist.com network, with 1 site in 1 country and 2 service areas.

View ICE Bioscience on Scientist.com

Sign in to Scientist.com to open this supplier in your organization's marketplace.

Email me this page as a PDF

Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Sites 1
Countries 1

Services

What this research supplier says it provides, as listed in the Scientist.com network.

Type of company: Small business

Agricultural Sciences Research & Development

  • DNA/Protein analysis Analyze DNA and proteins for allergens, pathogens and species identification.

Antibodies

  • Antibody based Assay Development Create specific and sensitive assays for the immunodetection of disease-specific target antigens.
  • Antibody Detection Quantitate, localize and visualize proteins and other antigens.
  • Antibody Therapy Efficacy In vivo assessment of monoclonal/bispecific antibody efficacy in a humanized mouse
  • Antibody-Dependent Cell-Mediated Cytotoxicity Request services related to cell-mediated immune defense.
  • Antibody-Drug Conjugation Improve therapeutic properties of an antibody or drug by joining them together.
  • Antigen Specific T-cells T cell lines that recognize specific peptide antigens to enable analysis of T cell immunity.
Show all 7 in Antibodies 1 more
  • Immunodetection Use antibodies to identify a protein or antigen.

Bioimaging

  • Bioimaging Visualize biological process non-invasively in real time.
  • Confocal/Optical Microscopy Use optical imaging technique to increase optical resolution and contrast of a micrograph.
  • In Vivo Whole Tissue and Animal Imaging Visualize, analyze and track light producing reporters in whole animals.
  • Luminescence Imaging Monitor biological processes and pathologies using reporter proteins such as firefly and Renilla luciferase.
  • Microscopy Use microscopy to analyze surfaces of biological materials and to develop 3D images of biological structures.
Show all 275 services 263 more

Biomarkers

  • Adipogenesis Assay Detect and quantify intracellular triglyceride accumulation in adipocytes.
  • Biomarker Discovery Identify a biomarker associated with disease progression of disease, effectiveness of therapy or diagnosis of disease or condition.
  • Cell Migration Assays Measure chemotaxis, haptotaxis, transmigration and wound-healing.
  • Cell Viability Measure changes in cell number, cell division, DNA content or a cell metabolism marker such as ATP levels.
  • Chemotaxis Assays Investigate the in vivo or in vitro movement of cells towards or away from a chemotactic agent.
  • Clinical Chemistry Measure analytes in serum, plasma, cells, tissue lysates or other biological materials.
Show all 21 in Biomarkers 15 more
  • Colony Forming Cell Assay Examine ability of hematopoietic stem cells to form colonies in vitro.
  • Customized Primary Cell Isolation Plan and execute the isolation of primary cells from a specific biosample.
  • Cytokine Release Assay Use in vivo or in vitro assays to detect unregulated or excessive release of pro-inflammatory cytokines.
  • Flow Cytometry Identify fluorescently-labeled cells or physically separate cells from a larger population using biomarkers.
  • Hematoxylin & Eosin (H&E) Staining Visualize microscopic structures in cells or tissues.
  • Histamine Release Assay Use in vivo or in vitro assays to measure the release of histamine in response to an allergen stimulation.
  • Human Primary Cell Isolation Isolate primary cells from various human tissues.
  • Immunoassays Create antibody-based assays for the identification and quantification of specific antigens.
  • Immunophenotyping Separate cell types based on their expression of biomarkers or based on their individual and unique expression patterns.
  • Immunostaining Use labeled antibodies to detect proteins or other antigens in cells or tissues.
  • Interferon Gamma Release Assay Use in vivo or in vitro assays to measure the cell-mediated immune response to an infectious agent.
  • Lipid Kinase Assays Use biochemical, cell-based or in vivo assays to measure lipid kinase activity.
  • Propidium Iodide FACS Analysis Use DNA staining and flow cytometry to analyze the cell cycle and detect apoptosis or cell proliferation.
  • Single Cell Isolation Isolate single cells for subsequent single-cell analysis.
  • T Cell Epitope Characterization Evaluate the potency and immunodominance of T-cell epitopes within a molecule.

Cell Culture and Characterization

  • 3D Cell Culture Use a scaffold-based or scaffold-free format to grow three dimensional cell and tissue structures.
  • Adherent Cell Culture Grow monolayers of anchorage-dependent cells.
  • Cell Line Characterization Track source history and characterize cell lines to establish identity, purity and stability.
  • Cell Line Construction Create new recombinant cell lines to exact specifications.
  • Cell Sorting The purpose of cell separation is to isolate a cell population from other cells in a biological sample.
  • Cell Transfection Produce, package and optimize transfection of your siRNA or DNA construct.
Show all 10 in Cell Culture and Characterization 4 more
  • Histology Examine by microscopy the anatomy of cells and tissues of clinical patients and animal models.
  • Microsatellite Instability Analysis Compare allelic profiles and detect genomic instability.
  • RNA-Based Transfection Deliver RNA to cells by microinjection, electroporation or lipid-mediated transfection.
  • Signaling Pathways Find proteins, assays and custom reagents for the analysis of cell signaling pathways.

Chemical and Compound Analysis

  • High Resolution MS Elucidate the sequence and structure of peptides, proteins, biomarkers and organic compounds.
  • Isothermal Titration Calorimetry An ITC assay will be established and optimised for the affinity measurement of test substance to target molecule.
  • Liquid Chromatography Separate substances using a mobile and stationary phase.
  • Non GLP Large Molecule Bioanalysis Detect and analyze the pharmacokinetic profile of large biomolecules.
  • Non GLP Small Molecule Bioanalysis Detect and analyze the pharmacokinetic profile of small molecules.
  • Protein Separation and Detection Separate proteins based on properties such as solubility, adsorption or size differences.
Show all 7 in Chemical and Compound Analysis 1 more
  • Sample Bioanalysis Determination of concentration of an analyte in biological sample.

Chemistry, Manufacturing and Controls (CMC)

  • Chemistry, Manufacturing and Controls (CMC) Request Chemistry, Manufacturing and Controls services

Clinical Consulting

  • Cell Services Consulting Whether you are an experienced drug hunter working in the pharmaceutical industry or an academic researcher looking to submit g...

Discovery Chemistry

  • LCMS Analysis Physically separate substances using liquid chromatography and mass spectrometry.
  • Structure Property Relationship (SPR) Determine the functionality of a compound through the analysis of it's structure.
  • Transporters Selectively screen for compounds with good permeability in the intestine, skin, or blood-brain barrier using drug transporter a...

Disease Models

  • Electroencephalogram EEG Models Record electrical activity along the scalp of animal models or human patients.
  • Ischemia Models Measure therapeutic endpoints in animal models of ischemia.
  • Liver Disease Animal Models Measure therapeutic endpoints in animal models with liver disease.
  • Neuroscience Models Test therapeutic efficacy of drug candidate in neurological disease model.
  • Stroke Models Measure therapeutic endpoints in animal models of stroke.
  • Xenografts Evaluate drug candidate in tissue graft or organ transplant model.

DNA & RNA

  • Capillary Electrophoresis Separate ng quantities of DNA to single base resolution.
  • cDNA cloning & subcloning Move cDNA fragments between different cloning vectors.
  • Cloning/Subcloning Clone or Subclone nucleotide sequence or gene.
  • DNA Extraction Extract DNA from an original source.
  • DNA Library Screening Screen genomic or cDNA libraries for positive clones.
  • DNA/RNA Extraction & Purification DNA/RNA Extraction & Purification.
Show all 15 in DNA & RNA 9 more
  • Genomic DNA Purification Isolate genomic DNA from cells or tissue samples.
  • Knockout/Knockin Cell Lines Develop Knockout/Knockin Cell Line.
  • Methylation Analysis Determine genomic methylation patterns and analyze methylation in tumors and treated samples.
  • mRNA synthesis Transcribe mRNAs in vitro and add modifications such as polyadenylation and guanine capping.
  • Plasmid DNA Preparation and Extraction Prepare plasmid DNA starting from E. coli cell pellets, transformed colonies or DNA samples.
  • qPCR Analysis Measure the accumulation of PCR products in real time.
  • Quantitative RT PCR Use quantitative reverse transcription polymerase chain reaction to measure absolute and relative mRNA abundance.
  • RNA Profiling Quantify the expression levels of mRNA transcripts, enabling the determination of gene expression patterns.
  • Target Gene Expression Measure expression of a target gene at the protein, RNA and DNA level.

Drug Development

  • Assay Development Consulting Request consultant services measuring the activity of a drug or biochemical in an organism or organic sample.
  • Cellular Immunology Consulting Immunological activities of cells in experimental or clinical situations
  • Safety Pharmacology Consulting Consulting services that help with the detection of potential undesirable pharmacodynamic effects of chemical entities on physiological functions.
  • Target Validation Consulting Help to demonstrate that modification of target activity has potential therapeutic benefits.

In Vitro ADME

  • Blood Brain Barrier Measure movement of drugs from circulating blood to brain extracellular fluid.
  • Caco-2 Cell Permeability Measure passive diffusion of drugs across Caco2 cell monolayers.
  • Cell Permeability and Absorbance Models Cell Permeability and Absorbance Model assay.
  • Compound Distribution Determine the metabolic fate of a drug candidate in tissue and organs of diseased and normal animal models.
  • CYP Induction Detect increases in the expression of various isoforms of cytochrome P450 (CYP450).
  • CYP Inhibition Assay Assess the inactivation and inhibition of cytochrome P450 (CYP450) in microsomes isolated from primary human hepatocytes or liver.
Show all 28 in In Vitro ADME 22 more
  • CYP Isozyme Mapping Determine the isozymes of cytochrome P450 (CYP450) involved in the metabolism of a drug candidate.
  • Cytochrome P450s Assess the inhibition or induction of the various isozymes of cytochrome P450s by drug candidates.
  • Drug Distribution Studies Determine the metabolic fate of compounds within tissues, organs and plasma.
  • Drug Drug Interactions Determine whether a substance affects the activity of a drug when both are administered together.
  • GI Fluid Stability Determine dosing and turnover of drug candidates in gastrointestinal fluids.
  • Intestinal Permeability Use Caco 2 and MCDK cells to assess mono-directional drug transport by passive diffusion in culture.
  • Membrane Transporters Use Caco 2 cells to assess bi-directional drug transport in the presence or absence of P-glycoprotein (P-gp) inhibitors.
  • Metabolic Stability Measure metabolic vulnerability to drug metabolizing enzymes using cell-free, cell-based and in vivo assays.
  • Metabolic Stability in Hepatocytes Assess the susceptibility of drugs to metabolism by Phase I (CYP450) and Phase II enzymes in liver cells.
  • Metabolic Stability in Microsomes Assess the susceptibility of drugs to metabolism by Phase I (CYP450) and Phase II enzymes in liver microsomes.
  • Metabolite Generation Analyze the formation of drug metabolites after administration of drug to an animal model or patient.
  • Metabolite Identification Identify drug metabolites that are formed after administration of drug to an animal model or patient.
  • Metabolite Identification and Profiling Estimate drug candidate metabolites after administration of drug to an animal or human subject.
  • Metabolite Quantification Quantify drug metabolites formed after drug administration to an animal model or patient.
  • Metabolite Structural Elucidation Use analytical tools to characterize metabolite structure.
  • No Label Methods Use mass spectrometry to detect and identify non-radiolabeled drug intermediates in pre-clinical samples.
  • Phase I Metabolism Use enzymes such as cytochrome P450 oxidases to introduce reactive or polar groups into xenobiotics.
  • Phase II Metabolism Use transferase enzymes such as glutathione S-transferases to conjugate phase I xenobiotics to polar compounds.
  • Plasma Stability Assay Determine degradation rate of drug candidates in plasma.
  • Protein Binding Ultrafiltration Measure the rate at which unbound drug passes through a dialysis membrane that models epithelial barrier pore size.
  • Reactive Metabolite Ensure that your drug candidate is not generating toxic reactive metabolites in vivo.
  • Red Blood Cell (RBC) Partitioning (Blood/Plasma Ratio) Measure the distribution of a compound between red blood cells and plasma.

In Vitro Assays

  • 3D Cell Microscopy Assay Investigate cellular and subcellular events in three dimensional 3D cultures by using fluorescence microscopy.
  • Annexin V Apoptosis Assay Detect and quantify apoptotic cells based on loss of membrane asymmetry.
  • Apoptosis Assays Detect apoptotic events that lead to programmed cell death.
  • Apoptotic Cell Staining Detect apoptotic cells in culture.
  • Assay Development Construct or create new assays or modify existing ones.
  • Biosensor Assays Evaluate biological activity of new compounds, detect toxic metabolites or monitor biomarkers.
Show all 33 in In Vitro Assays 27 more
  • BrdU S-Phase Analysis Assess cell division or apoptosis by measuring thymidine-analog label incorporation during DNA replication.
  • Caspase Assay Detect early to mid stage apoptosis or differentiate apoptosis from necrosis.
  • Cell Based Assays Apply compounds to cells and test for cellular phenotypes and effects on gene expression
  • Cell Based Assays Consulting Expert advice to evaluate the functions of specific chemicals based on their constructions and systems.
  • Cell Cycle Assays Measure cell cycle markers and the molecular events that control cell cycle progression.
  • Cell Proliferation Measure cell number, cell viability and cell division.
  • Cytometric Bead Array (CBA) FACS Analysis Use flow cytometry and antibody-coated beads to simultaneously detect multiple target proteins.
  • Epigenetic Profiling In Vitro Assays Test for epigenetic modifications and indicator levels via in vitro assays.
  • Fully Automated Assays Develop and perform assays that require no manual steps
  • Glucose Release Assay Determine free glucose levels in biological samples.
  • High Content Screening Analyze whole cells or components of cells with simultaneous readout of several parameters.
  • HTS Assay Development Develop assays to use in high throughput screening.
  • Hydroxyproline Assays Use biochemical, cell based or in vivo assays to quantify hydroxyproline or collagen in a sample.
  • In Vitro Assay Development Develop innovative assay and screening methods outside a living organism to enable a wide range of pre-clinical activities.
  • In Vitro Efficacy Test Use in vitro models to test the efficacy of your products.
  • Inflammation Assays Identify and validate pro- and anti-inflammatory molecules, recruitment inhibitors and chemotaxis modulators.
  • Invasion Assays Monitor and quantify the ability of cultured cells to permeate real or artificial biological barriers.
  • Lipid Detection Use in vitro methods to identify lipid droplets and any associated proteins.
  • Lipolysis Measure the hydrolysis of triglycerides into glycerol and free fatty acids.
  • Luciferase Reporter Assay Evaluate promoter activity by measuring light output from the luciferase enzyme.
  • Oxidative Burst Examine the release of reactive oxygen species (ROS) from neutrophils and other immune cells.
  • Pathway Mapping Define mechanisms of action by analyzing protein pathways affected by drug treatment.
  • Phenotype Assays Measure effects of drug candidate on the morphology or function of cells and whole animals.
  • Reactive Species Assays Use biochemical, cell-based or in vivo assays to detect and evaluate the effects of reactive species.
  • Serine Protease Assay Detect apoptosis by measuring protease activity.
  • Stem Cell Differentiation Microscopy Assay› Elucidate mechanisms of stem cell renewal and differentiation in vitro using fluorescence microscopy.
  • Tube Formation Assay Monitor the in vitro formation of three dimensional 3D tube structures.

In Vitro Pharmacology

  • Anaplastic lymphoma kinase (ALK) Assays Use biochemical, cell based or in vivo assays to measure ALK enzyme activity.
  • B-Cell Lymphoma 2 (BCL-2) Assays Use biochemical, cell based or in vivo assays to measure BCL-2 protein activity.
  • Calcium Channel Assays Use biochemical, cell-based or in vivo assays to measure calcium channel activity.
  • Chloride Channel Assays Use biochemical, cell-based or in vivo assays to measure chloride channel activity.
  • Cytotoxic T-Lymphocyte Antigen-4 (CTLA-4) Assays Use biochemical, cell based or in vivo assays to measure CTLA-4 receptor activity.
  • Drug Target Assays Gain insight into the selectivity and mode-of-action of a compound's pharmacological targets.
Show all 61 in In Vitro Pharmacology 55 more
  • Extracellular signal Regulated Kinase Assays Use biochemical, cell based or in vivo assays to measure ERK enzyme activity.
  • Fibroblast Growth Factor Receptor (FGFR) Assays Use biochemical, cell based or in vivo assays to measure FGF receptor activity.
  • G-Protein Coupled Receptor (GPCR) Assays Detect ligand binding, receptor dimerization and downstream signal transduction events.
  • Glucose Transporter Assays Use biochemical, cell-based or in vitro assays to measure glucose transporter activity.
  • High Throughput Screening Conduct millions of chemical, genetic or pharmacological tests in a short period of time.
  • Histone Acetyltransferase (HAT) Assays Use biochemical, cell-based or in vivo assays to measure histone acetyltransferase activity.
  • Histone Deacetylase (HDAC) Assays Use biochemical, cell-based or in vivo assays to measure histone deacetylase activity.
  • HuGEMM - Immuno-Oncology Model Evaluate human-specific therapeutics for checkpoint inhibitors, including anti-human PD-1, anti-human PDL-1, and anti-human CTLA-4 antibodies.
  • Human BCL Assays Use biochemical, cell-based or in vivo assays to measure BCL activity.
  • Human Epidermal growth factor Receptor (HER) Assays Use biochemical, cell based or in vivo assays to measure HER receptor activity.
  • Immuno-oncology Assays Use biochemical, cell based or in vivo assays to measure the activity of immuno-therapy targets.
  • Immuno-oncology Targets Develop drugs that take advantage of the immune system to target cancer cells.
  • In Vitro Diabetes Models Measure insulin stimulation of glucose uptake and metabolism of lipids including cholesterol and triglycerides.
  • In Vitro Disease Models Screen pre-clinical candidates without the use of live animals.
  • In Vitro Enzyme Activity Assay Development Develop new in vitro enzyme activity assays or modify existing ones.
  • In Vitro Excitotoxicity Models Use in vitro models to measure therapeutic endpoints associated with excitotoxic pathology.
  • In Vitro Hepatotoxicity Assays Use in vitro assays to measure hepatoxicity-related activities.
  • In Vitro Hypoxia Models Use in vitro models to measure therapeutic endpoints associated with hypoxia.
  • In Vitro Oncology Models Use cell-based and biochemical models of cancer.
  • Ion Channels Use fluorometry, electrophysiology and radiometric binding assays to measure ion channel activity.
  • Kinase Assays Measure activity of over 500 kinases in biochemical or cell-based assays.
  • Liposome Immunoassay Use immuno-liposomes for improved signal intensity and detection sensitivity compared to enzyme and fluorescent immunoassays.
  • Mammalian Target of Rapamycin Complex Assays Use biochemical, cell based or in vivo assays to measure mTORC enzyme activity.
  • Methyltransferase Assays Use biochemical, cell-based or in vitro assays to measure methyltransferase activity.
  • Mitogen/Extracellular signal-regulated Kinase (MEK) Assays Use biochemical, cell based or in vivo assays to measure MEK enzyme activity.
  • Mutant B-Raf Assays Use biochemical, cell based or in vivo assays to measure mutant B-Raf enzyme activity.
  • Nuclear Receptor Assays Measure nuclear receptor activity in biochemical and cell assays.
  • PARP Assays Use biochemical, cell-based or in vivo assays to measure PARP activity.
  • Phosphatase Assays Use biochemical, cell-based or in vitro assays to measure phosphatase activity.
  • Phosphatidylinositol 3-Kinase (PI3K) Assays Use biochemical, cell based or in vivo assays to measure PI3K enzyme activity.
  • Phosphodiesterase Assays Measure phosphodiesterase activity in biochemical and cell-based assays.
  • Polymerase Assays Measure polymerase activity in biochemical and cell-based assays.
  • Potassium Channel Assays Use biochemical, cell-based or in vivo assays to measure potassium channel activity.
  • Programmed Cell Death-1 (PD-1) Assays Use biochemical, cell based or in vivo assays to measure PD-1 receptor activity.
  • Programmed Death-Ligand 2 (PD-L2) Assays Use biochemical, cell based or in vivo assays to monitor competitive or non-competitive binding of PD-L2 ligand.
  • Protease Assay Measure protease activity in biochemical and cell-based assays.
  • Protein Kinase B (Akt) Assays Use biochemical, cell based or in vivo assays to measure Akt enzyme activity.
  • Protein Targets Protein Targets are of pharmaceutical interest for drug discovery purposes.
  • Protein/Enzyme Targets For requesting Protein/Enzyme Targets
  • Raf Assays Use biochemical, cell based or in vivo assays to measure Raf enzyme activity.
  • RAS Assays Use biochemical, cell based or in vivo assays to measure RAS enzyme activity.
  • Reversibility Study Determine whether or not a compound inhibits an enzyme reversibly.
  • Selectivity Profiling Determine the specificity of a ligand for its target by testing it against a large panel of related target proteins.
  • Sodium Channel Assays Use biochemical, cell-based or in vivo assays to measure sodium channel activity.
  • Solute-Linked Carrier (SLC) Transporter Inhibition Assays Use biochemical, cell-based or in vivo assays to measure solute-linked carrier transporter activity.
  • Solute-Linked Carrier (SLC) Transporter Substrate Identification Use biochemical, cell-based or in vivo assays to identify solute-linked carrier transporter substrates.
  • Substrate Competitive Study Determine whether or not a compound is competitive with a substrate.
  • Target Characterization Characterize potential drug targets during the drug discovery process.
  • Target Identification Identify the target(s) of a biologically active substance.
  • Target Validation Demonstrate that modification of target activity has potential therapeutic benefits.
  • Time Dependent Study Determine whether or not a compound binds to an enzyme in a time-dependent manner.
  • Transporter Assays Use biochemical, cell-based or in vitro assays to measure transporter target activity.
  • Ubiquitin Ligase Assays Measure ligase enzyme activity in the presence of cofactors or chemical modifiers.
  • Vascular Endothelial Growth Factor (VEGF) Assays Use biochemical, cell based or in vivo assays to monitor competitive or non-competitive binding of VEGF ligand.
  • Vascular Endothelial Growth Factor Receptor (VEGFR) Assays Use biochemical, cell based or in vivo assays to measure VEGF receptor activity.

In Vitro Toxicology

  • ADCC and CDC Assay Services Measure toxicity of antibodies.
  • Cardiac Channels Measure the arrhythmia producing potential of test compounds.
  • Cardiomyocyte Toxicity Assess cytotoxic effects of pre-clinical compounds on cardiomyocytes.
  • Cardiotoxicity Evaluate the effect of a compound on heart electrophysiology and muscle function.
  • Cytotoxicity Test for effects on cell viability and proliferation
  • Cytotoxicity Testing Determine whether a cosmetic product or ingredient is toxic to in vitro cell cultures.
Show all 11 in In Vitro Toxicology 5 more
  • Hematopoietic Cell Toxicity Examine cytotoxic effects of pre-clinical compounds or biologics on adult stem cells.
  • HepaRG Cells Obtain terminally differentiated and cryopreserved hepatic cells that retain many characteristics of primary human hepatocytes.
  • Hepatocyte Toxicity Assess the cytotoxic effects of pre-clinical compounds on hepatocytes purified from patients and animal models.
  • hERG Inhibition Measure the arrhythmia-producing potential of test compounds.
  • Tubule Epithelial Cell Toxicity Assess the cytotoxic effects of pre-clinical compounds on the kidney.

In Vivo ADME

  • Absorption studies Study the factors determning how efficiently a compound may enter the bloodstream.
  • Chronic Bile Duct Cannulation (BDC) Study - Other Species Conduct a bile duct cannulation (BDC) study in other species to support the absorption, distribution, metabolism and excretion profiling of your compound.
  • Chronic Bile Duct Cannulation (BDC) Study - Rat Conduct a bile duct cannulation (BDC) study in rats to support the absorption, distribution, metabolism and excretion profiling of your compound.
  • Tissue Distribution Study the tissues in which a compound or its metabolites, accumulate.

In Vivo Pharmacokinetics

  • In Vivo Pharmacokinetics Run pharmacokinetic studies in animals that measure a drug's absorption, distribution, metabolism and excretion (ADME).
  • In Vivo PK Consulting Expert advice on pharmacokinetics and how specific drugs affect the body to determine function, effectiveness, dosage size, etc…
  • Mass Balance Elucidate excretory pathways and organ distribution of a parent drug and metabolites
  • Pharmacokinetic (PK) Screening Measure the absorption, distribution, metabolism and excretion of a compound.
  • Pharmacokinetic (PK) Screening - Dog / Canine Run pharmacokinetic studies in dogs that measure a drug’s absorption, distribution, metabolism and excretion.
  • Pharmacokinetic (PK) Screening - Monkey / Non-human Primate Conduct a pharmacokinetic screening study in monkeys/non-human primates that measures the absorption, distribution, metabolism and excretion of your compound.
Show all 11 in In Vivo Pharmacokinetics 5 more
  • Pharmacokinetic (PK) Screening - Mouse Run pharmacokinetic studies in mice that measure a drug's absorption, distribution, metabolism and excretion.
  • Pharmacokinetic (PK) Screening - Other Species Run pharmacokinetic studies in large animals that measure a drug's absorption, distribution, metabolism and excretion.
  • Pharmacokinetic (PK) Screening - Rat Run pharmacokinetic studies in rats that measure a drug's absorption, distribution, metabolism and excretion.
  • Repetitive Maximum Tolerated Dose (MTD) Mouse Study Use mouse models to determine the MTD of a drug candidate by repetitive administrations for 7 days.
  • Repetitive Maximum Tolerated Dose (MTD) Rat Study Use rat models to determine the MTD of a drug candidate by repetitive administrations for 7 days.

Model Development

  • Animal Model Development Create new systems for profiling pre-clinical therapeutics, devices, and surgical techniques.
  • Fresh Functional Human Tissue Efficacy Assays Use fresh functional human tissue to assess pre-clinical efficacy of test compounds.
  • Fresh Functional Human Tissue Safety Assays Use fresh functional human tissue to assess pre-clinical safety of test compounds.
  • SCID Mouse Use a single animal species to create one or more disease models for spontaneous and metastatic cancer and cachexia.
  • SCID/BG Mouse Use a single animal species to create one or more disease models for metastatic cancer.
  • Standard Models Create new animal disease models or modify existing models to study specific diseases, side-effects or symptoms.
Show all 7 in Model Development 1 more
  • Transgenic Models Create animal models engineered for use in a specific therapeutic area.

Oncology Models

  • Animal Hypoxia Models Measure therapeutic endpoints in hypoxic animal models.
  • NCG Model Study tumor biology and immuno-oncology in the CRISPR/Cas9-generated immunodeficient mouse model.
  • Xenograft Models Measure therapeutic endpoints in cancer models using tumor cells transplanted from a donor of a different species.

Product Orders

  • Kits and Reagents Submit a request to multiple vendors for kits and reagents.

Protein Sciences

  • Affinity Tag Purification Purify proteins under physiological conditions at their native cellular levels.
  • Antibody-Antigen Affinity Measurement Measure the binding kinetics of an antibody–antigen interaction.
  • Bacterial Expression Produce milligram, gram and kilogram amounts of proteins.
  • Cytokines Find recombinant cytokines or cytokine assays.
  • ELISA Detect the presence of antigens recognized by antibodies or find antibodies that recognize an antigen.
  • Enzymology Enzymology studies the biochemical activity, structure, and function of enzymes. Two key area of Enzymology are Cytochrome P450...
Show all 27 in Protein Sciences 21 more
  • Fluorescence Polarization Investigate receptor-ligand interactions, protein-DNA interactions, proteolysis and membrane fluidity.
  • Immunoprecipitation Precipitate a protein of interest out of solution using an antibody to which it binds.
  • Insect Expression Use baculovirus infected cells or non-lytic cell systems to produce glycosylated proteins.
  • LCMS/MS Analysis Liquid chromatography–mass spectrometry is an analytical chemistry technique that combines the physical separation capabilities of liquid chromatography with the mass analysis capabilities of mass spectrometry.
  • Mammalian Expression Express high yields of recombinant proteins, antibodies, virus, viral-subunit proteins and gene-therapy vectors.
  • Mass Spectrometry-Based Proteomics Detect histone post-translational modifications (hPTMs), histone variants, and interactomes at chromatin regions.
  • Native Protein Purification Purify native proteins from sources such as tissue & serum.
  • Phosphorylation Analysis Identify phosphorylation sites in target proteins.
  • Protein Binding Determine drug-protein binding interactions
  • Protein Identification Uncover or confirm the identity of a protein.
  • Protein Interaction Measure the interaction of a protein to other macromolecules or peptide ligands.
  • Protein Production Produce recombinant protein molecules in prokaryotic or eukaryotic systems.
  • Protein Products Find native and recombinant proteins and peptides.
  • Protein Purification Isolate native or recombinant proteins from a sample.
  • Protein Services Consulting Expert advice to evaluate and analyze protein function and expression.
  • Proteomics Do large-scale experimental analysis of proteins focused on understanding structure and function.
  • Qualitative MS Perform direct identification of molecules based on mass-to-charge ratio and fragmentation patterns.
  • Quantitative MS Quantify small and large molecules in the pg/ml range
  • Recombinant Proteins Use recombinant DNA to produce proteins in vivo or in vitro.
  • Surface Plasmon Resonance (SPR) Measure interactions of biomolecules including antibodies, vaccines, biomarkers and small molecules.
  • Western Blots Detect specific proteins in a sample of tissue homogenate or extract.

REACH Services

  • OECD 432: In Vitro 3T3 NRU Phototoxicity Test Test the cytotoxic effects of chemical substances and environmental samples on cell membranes.

Safety Pharmacology

  • Immunotoxicity Measure effects of drugs on immune function, allergic hypersensitization and autoimmune toxicity.
  • Off Target Effects Assess toxicities by body weight, clinical chemistry, hematology, urinalysis and terminal necropsy and pathology.
  • Safety Pharmacology Assess the impact of a therapeutic for human use on vital organ systems before first-in-man drug testing.
  • Target Safety Assessment Understand the role of your drug target and assess risks in normal physiology.

Scientific Data Services

  • Bioinformatics Bioinformatics is a powerful method of storing, retrieving and analyzing biological data.

Testing Services

  • Membrane Permeability (PAMPA) Parallel Artificial Membrane Permeability Assay (PAMPA) - Measure passive diffusion of drugs by the parallel artificial membrane permeation assay.

Other services

  • New Request  

Service areas:

Biology Toxicology

Source: Scientist.com supplier network

Where it operates

Sites by country, with the cities in each.

  • China Tongzhou 1 site

Source: Scientist.com supplier network (site locations)

About this supplier

In the supplier's own words, as listed in the Scientist.com network.

ICE-Bioscience Co., Ltd. is a rapidly growing Chinese-based biotech company specialized on in vitro research services. The company is the pioneer of ion channel drug research in the Chinese preclinical CRO market. ICE-Bioscience offers preclinical services in the ion channel drug discovery and hERG channel related cardiac safety assessments. The company has established the automated and manual patch clamp platform and the fluorescence-based ion channel screening platform. ICE-Bioscience provides a flexible, high quality, efficiency service with low cost that meets the needs of a wide range...

Show the full description

ICE-Bioscience Co., Ltd. is a rapidly growing Chinese-based biotech company specialized on in vitro research services. The company is the pioneer of ion channel drug research in the Chinese preclinical CRO market. ICE-Bioscience offers
preclinical services in the ion channel drug discovery and hERG channel related cardiac safety assessments. The company has established the automated and manual patch clamp platform and the fluorescence-based ion channel screening platform. ICE-Bioscience provides a flexible, high quality, efficiency service with low cost that meets the needs of a wide range of biotech and pharmaceutical companies.

Website
en.ice-biosci.com

Source: Scientist.com supplier network, written by the supplier

Get the ICE Bioscience report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Sources: Scientist.com supplier network.

Work with ICE Bioscience on Scientist.com

For prices, more details, or to contact ICE Bioscience, visit Scientist.com.

Sign in to Scientist.com to open this supplier in your organization's marketplace.